E2 ModeratePreliminaryPEM not requiredObservationalPeer-reviewedReviewed
Standard · 3 min
Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment.
Langsjoen, P H, Langsjoen, P H, Folkers, K · The Clinical investigator · 1993 · DOI
Quick Summary
This study looked at heart function in patients with chronic fatigue syndrome (ME/CFS) and compared them to patients with other heart conditions. Researchers found that many of these patients had a specific type of heart problem called diastolic dysfunction—where the heart doesn't relax properly between beats. When patients were given a supplement called CoQ10, their heart function improved and their symptoms got better.
Why It Matters
Many ME/CFS patients experience cardiac symptoms including fatigue, chest pain, and palpitations that may relate to diastolic dysfunction—an energy-dependent cardiac process. This study suggests that CoQ10, which plays a critical role in cellular energy production, may improve both cardiac function and symptom severity in ME/CFS patients, potentially offering a therapeutic avenue for this under-treated symptom cluster.
Observed Findings
All 115 patients at baseline showed diastolic dysfunction on echocardiography despite different underlying diagnoses.
Mean baseline CoQ10 blood level was 0.855 micrograms/ml across the cohort.
CoQ10 supplementation resulted in improved diastolic function in all patients with follow-up echocardiograms.
Myocardial hypertrophy was reduced in 53% of hypertensive patients and 36% of combined mitral valve prolapse/CFS patients after CoQ10 treatment.
Blood pressure reduction occurred in 80% of patients receiving CoQ10 treatment.
Inferred Conclusions
Diastolic dysfunction is a common feature across fatigue-associated conditions and may reflect impaired myocardial energy metabolism.
CoQ10 replacement improves diastolic function across diagnostic groups, suggesting a shared energy-dependent mechanism.
CoQ10 supplementation may have therapeutic benefit for patients with fatigue and diastolic dysfunction regardless of primary diagnosis.
Chronic CoQ10 depletion may contribute to both cardiac dysfunction and fatigue symptoms in ME/CFS.
Remaining Questions
What are the optimal CoQ10 dosing regimens and target serum levels for ME/CFS patients with diastolic dysfunction?
What This Study Does Not Prove
This observational study cannot establish causation or prove that CoQ10 definitively improves diastolic function in ME/CFS; without a placebo control group, improvement could reflect natural history, placebo effect, or concurrent lifestyle changes. The study does not demonstrate that diastolic dysfunction is the primary cause of ME/CFS symptoms, only that it occurs frequently in patients with these symptoms. It also does not identify which ME/CFS patients would most benefit from CoQ10 or provide optimal dosing guidance.
Tags
Symptom:PainFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionExploratory OnlyMixed CohortSmall Sample
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.